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1. Introduction  
REM sleep behavior disorder (RBD) is a parasomnia characterized by dream-enacting 
behavior and vivid, action-filled or unpleasant dreams and presents a risk for self-injury 
and harm to others (e.g., a bed partner) due to abnormal REM sleep during which control 
of muscle tonus is lacking. Polysomnography is required to establish the diagnosis and 
represents the diagnostic gold standard for revealing loss of REM-related muscle atonia 
with excessive sustained or intermittent elevation of submental EMG tone or excessive 
phasic submental or limb EMG twitching. Idiopathic RBD (iRBD) has a male 
preponderance and usually emerges after the age of 50 and has a known association with 
neurodegenerative diseases, in particular the α-synucleinopathies such as Parkinson’s 
disease (PD), dementia with Lewy body disease and multiple system atrophy (Schenck & 
Mahowald, 2002). Even more important, evidence is growing that iRBD precedes 
parkinsonism by years or even decades, and that iRBD might present an early stage in the 
development of neurodegenerative disorders (Schenck et al., 1996). Thus, to identify 
clinical RBD as early as possible appears to be useful for early diagnosis, a clinical trial 
with a potentially neuroprotective substance, and also for epidemiological studies. To 
meet the need for an easily applicable diagnostic screening tool, Stiasny-Kolster et al. 
developed and validated a specific screening scale for assessment of RBD, the RBD 
screening questionnaire (RBDSQ) (Stiasny-Kolster et al., 2007). Subsequently we 
developed a Japanese version of the RBDSQ (RBDSQ-J) after obtaining approval from the 
patent owner and investigated its validity and reliability (Miyamoto et al., 2009). We 
found that detection of RBD using the RBDSQ-J would be useful in the stepwise 
diagnostic process. We will discuss screening methods for RBD and describe RBD 
screening questionnaires, including the RBDSQ-J. 
2. Prevalence of REM sleep behavior disorder 
The overall prevalence of RBD remains largely unknown. A large telephone survey using 
the Sleep-EVAL system for assessing violent behaviors during sleep in the general 
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population (4972 individuals aged 15-100 years) in the United Kingdom suggested an 
estimated prevalence of RBD of about 0.5% (Ohayon et al., 1997). A study of 1034 elderly 
subjects aged 70 years or above in the Hong Kong area found an estimated prevalence of 
polysomnography (PSG)-confirmed RBD of 0.38% (Chiu et al., 2000). There is a male 
predominance (87%) with primarily men over the age of 50 being affected (Schenck & 
Mahowald, 2002). Boeve summarized the demographics and clinical phenomenology of 
RBD (Table 1) (Boeve, 2010a). 
 
 
 
 
Table 1. Demographics and clinical phenomenology of RBD (Modified from Boeve, 2010a) 
3. Diagnosis for REM sleep behavior disorder 
Until recently, the diagnosis of RBD was based on clinical manifestations, namely the 
presence of limb or body movements associated with dream mentation and at least one of 
the following: (1) harmful or potentially harmful sleep behaviors during sleep; (2) dreams 
that appear to be acted out; and (3) sleep behaviors that disrupt sleep continuity. 
Polysomnographic observations of patients were not necessary for diagnosis according to 
the International Classification of Sleep Disorders-1 (ICSD-1).  
Eisensehr et al. and Gagnon et al. pointed out the limitations of these criteria because one 
half of the cases of RBD with PD would have been undetected based clinical interviews 
alone (Eisensehr et al., 2001; Gagnon et al., 2002). RBD-like features can occur with other 
sleep conditions such as obstructive sleep apnea syndrome (OSAS), sleepwalking, night 
terrors, and sleep-related seizures (see below 4). In the second version of the ICSD (ICSD-2), 
PSG findings were required to establish the diagnosis. The first essential criterion is the 
presence of REM sleep without atonia. The second criterion is the presence of either sleep-
related injurious or disruptive behaviors revealed by history or abnormal REM sleep 
behaviors documented during PSG recording. Time-synchronized video recording is 
essential for helping to establish the diagnosis of RBD during PSG. The last two criteria are 
exclusion criteria, which are the absence of epileptiform activity during sleep and the 
presence of other sleep disorders or medical or neurological disorders that could better 
explain the sleep disturbance. The diagnostic criteria are listed in Table 2. 
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Table 2. Diagnostic criteria for REM sleep behavior disorder in ICSD-2 
4. Differential diagnosis of REM sleep behavior disorder 
RBD is a relatively rare condition and is largely unknown to most physicians (see above 2), 
therefore it is often misdiagnosed and mistreated. 
The differential diagnosis of recurrent dream enactment behavior includes NREM 
parasomnia, nocturnal panic attacks, nocturnal seizures, nightmares, nocturnal wandering 
associated with dementia, and OSAS (Boeve, 2010a). A complaint of nocturnal disruptive 
behaviors is the major clinical feature of several other conditions, such as primary and 
secondary disorders of arousal, dreaming, and panic disorders (Table 3).  
 
Primary disorders of arousal (from NREM sleep) 
  Confusional arousals 
  Sleepwalking 
  Sleep terrors 
Secondary arousal disorders 
  Obstructive sleep apnea syndrome (pseudo RBD) 
Sleep-related epilepsy 
Psychiatric diseases 
  Sleep-related dissociative disorder 
  Panic disorder 
  Posttraumatic stress syndrome 
Table 3. Differential diagnosis of RBD 
Primary arousal disorders from NREM sleep include confusional arousals, sleepwalking, and 
sleep terrors. In contrast to RBD, sleepwalking and sleep terrors are more frequent in children 
and rarely appear de novo in middle-aged or elderly individuals. They are also characterized 
by confusion and retrograde amnesia upon awakening at the time of nocturnal episodes; these 
phenomena are not seen in patients with RBD. In general, RBD involves attempted enactment 
of altered dreams and rapid awakening from an episode that usually occurs two or more 
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hours after sleep onset. In contrast, sleepwalking and sleep terror episodes often emerge 
within two hours after sleep onset, are not usually associated with rapid alertness, and are 
rarely associated with dreaming in children. Adults can have associated dreaming, but it is 
usually more fragmentary and more limited than RBD dreams. 
Severe OSAS and nocturnal epilepsy may mimic the symptoms of RBD. Patients with severe 
OSAS may present with unpleasant dreams and dream-enacting behaviors (Iranzo & 
Santamaria, 2005). Continuous positive airway pressure (CPAP) therapy can eliminate 
abnormal nocturnal behaviors. Sleep-related seizures usually present with repetitive 
stereotypical behaviors. 
When a diagnostic clarification is necessary, particularly when the risk for injury is high, the 
behaviors occur at any time of the night, other features suggesting an evolving 
neurodegenerative are present, or loud snoring and observed apnea suggestive of OSA are 
present, PSG with simultaneous video monitoring is warranted (Boeve, 2010a). 
5. The need for screening and screening methods for RBD 
PSG is clearly necessary for establishing the diagnosis of RBD, but the procedure requires 
appropriate monitoring equipment, including time synchronized video recordings, specially 
trained technologists, bed availability in a sleep laboratory, and clinicians who can interpret 
the data. The procedure is costly, especially for patients with limited insurance coverage. 
Subjects must be willing and able to sleep in a sleep laboratory and undergo monitoring. Some 
patients with coexisting neurologic disorders are too cognitively or physically impaired to 
tolerate and undergo an adequate study, are too uncooperative to permit all of the monitoring 
equipment to remain in place, are at risk for falls during the night, or are institutionalized. 
RBD cannot be accurately assessed in the home. Due to the limited number of sleep disorder 
centers in many countries, PSG is not possible even when clearly medically warranted. As it is 
impractical to perform PSG in large numbers of subjects in epidemiologic studies of sleep 
disorders, the availability of a simple, short, reliable, and accurate measure to screen for the 
presence of various sleep disorders would be highly valuable (Boeve, 2010a).  
A recent study suggested that a clinical interview by expert clinicians could provide good 
sensitivity (100%) and specificity (99.6%) in diagnosing RBD in non-PD patients (Eisensehr 
et al, 2001). The interobserver reliability of ICSD-R criteria for RBD was also found to be 
substantial (Bologna, Genova, Parma and Pisa Universities group for the study of REM sleep 
Behaviour Disorder (RBD) in Parkinson’s Disease, 2003). Nevertheless, conducting a useful 
clinical interview may require considerable expertise, training, time and resources. In 
addition, waiting times might be long for and access limited to clinical and PSG assessments 
in some medical settings. Hence, an easily applicable questionnaire may be considered as a 
supplemental assessment tool in clinical practice to provide a quick and accurate appraisal 
of RBD symptoms in order to prioritize assessment and intervention. 
We describe RBD screening questionnaires such as the Mayo Sleep Questionnaire (MSQ), 
RBDSQ (English/German version and Japanese version) and RBDQ-HK.  
5.1 Mayo sleep questionnaire 
RBD is a parasomnia that can develop in otherwise neurologically-normal adults as well as 
in those with a neurodegenerative disease. Confirmation of RBD requires PSG. A simple 
screening measure for RBD is desirable for clinical and research purposes. Boeve et al. 
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developed the Mayo Sleep Questionnaire (MSQ), a 16-item measure to screen for the 
presence of RBD, periodic legs movement disorder (PLMD), restless legs syndrome (RLS), 
sleepwalking, OSAS and sleep-related leg cramps (Boeve, 2010a; Boeve et al., 2002a, 2002b, 
2010b, 2011). The data presented herein refer to the primary question on RBD (Question 1); 
if the primary question is answered affirmatively, subquestions are asked (subquestions 1b-
e) as shown in Table 4. 
 
 
Table 4. Primary question on RBD in the Mayo Sleep Questionnaire (MSQ)  
(from the website: http://www.mayoclinic.org/pdfs/MSQ-copyrightfinal.pdf.) 
Among the community-dwelling elderly, the MSQ has high sensitivity (100%) and 
specificity (95%) for diagnosis of RBD and was particularly specific for RBD in the absence 
of an OSA feature (Boeve, 2010b). 
Boeve et al. also assessed the validity of the MSQ by comparing the responses of patients’ 
bed partners with the findings (REM sleep without atonia) on PSG. The study subjects were 
176 individuals (150 males; median age 71 years (range 39-90)) with the following clinical 
diagnoses: normal (n=8), mild cognitive impairment (n=44), Alzheimer’s disease (n=23), 
dementia with Lewy bodies (n=74), and other dementia and/or parkinsonian syndromes 
(n=27). Sensitivity and specificity for question 1 on the MSQ for PSG-proven RBD were 98% 
and 74%, respectively. They concluded that the MSQ has adequate sensitivity and specificity 
for the diagnosis of RBD among aged subjects with cognitive impairment and/or 
parkinsonism (Boeve et al, 2011). 
5.2 RBDSQ 
Stiasny-Kolster et al. in 2007 developed the original German/English RBD Screening 
Questionnaire (RBDSQ) (Stiasny-Kolster et al., 2007). The RBDSQ is a 10-item patient self-
rating instrument that assesses sleep behavior with short questions that have to be answered 
by either “yes” or “no” by the patient. Since patients do not always have a long-time 
companion, the bed partner’s input was encouraged but not required. Items 1 to 4 address 
the frequency and content of dreams and their relationship to nocturnal movements and 
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behavior. Item 5 asks about self-injuries and injuries of the bed partner. Item 6 consists of 
four subitems that assess nocturnal motor behavior more specifically, e.g., questions about 
nocturnal vocalization, sudden limb movements, complex movements, or items around the 
bed that fell down. Items 7 and 8 deal with nocturnal awakenings. Item 9 focuses on 
disturbed sleep in general and item 10 on the presence of any neurological disorder. The 
maximum total score for the RBDSQ is 13 points. The RBDSQ was applied to 54 RBD 
patients (mean age 53.7 years, range 19-79) who had been clinically diagnosed with iRBD 
(n=19), narcolepsy (n=33), early PD (n=2)) and 160 patients without RBD (age 50.8 years, 
range 20-83) who had been diagnosed as having RLS (n=73), narcolepsy (n=27), OSAS 
(n=21), hypersomnia (n=10), PLMD (n=8), insomnia (n=4), sleepwalking (n=4), epilepsy 
(n=3), nightmares (n=1), sleep bruxisum (n=1), or depression. (n=1). Also studied were 133 
healthy subjects (mean age 46.9 years, range 20-72). Using a cut-off value of five points on 
the RBDSQ as a discriminatory variable, the questionnaire revealed a sensitivity of 96% and 
a specificity of 56%, correctly diagnosing 66% of subjects with sleep disorders. They 
mentioned that the lower specificity might be due to the fact that most of their control 
patients had sleep disturbances or neurological disorders that are known to be associated 
with periodic leg movements, e.g., RLS, PLMD, narcolepsy, and OSAS. This selection bias 
predisposed to positive answers for items that are related either to limb movements such as 
items 4, 5, 6.2, and 7 or to the presence of sleep and/or neurologic disorders such as for 
items 9 and 10, leading to higher RBDSQ total scores and thus to a lower specificity. 
Considering its high sensitivity, the RBDSQ represents an adequate tool to detect subjects 
with RBD. In subjects without additional neurologic or sleep disorders, the specificity was 
high, but in patients with either neurologic diseases or sleep disorders, the specificity is 
poorer but acceptable. The authors demonstrated the RBDSQ might be applied within a 
stepwise diagnostic process (questionnaire, interview, PSG). 
5.3 RBDSQ-J 
We developed a Japanese version of the RBDSQ (RBDSQ-J) after obtaining approval from 
the patent owner and investigated its validity and reliability (Miyamoto et al., 2009). The 
RBDSQ-J was administered to 52 consecutive patients with iRBD diagnosed according to 
criteria in the ICSD-2 (mean age 66.4 years; 36 males, 16 females), 55 consecutive OSAS 
patients who had responded well to CPAP therapy (mean age 63.1 years; 44 males, 11 
females) after a diagnosis of RBD was ruled out by history and PSG and 65 apparently 
healthy subjects (mean age 64.6 years; 37 males, 28 females).  
The mean RBDSQ-J scores for the iRBD group, the OSAS group and the healthy subjects 
were 7.5, 1.9, and 1.6 points, respectively. Sensitivity and specificity using a cut-off of 4.5 
were high in differentiating the iRBD group from healthy subjects or the OSAS group. An 
RBDSQ-J score cut-off of 5.0 was considered useful for differentiating the iRBD group from 
the healthy subjects or the OSAS group. Cronbach’s alpha for the entire RBDSQ-J was 0.866. 
The RBDSQ-J score had no correlation with the duration of RBD (mean disease duration in 
the iRBD group from symptom onset was 4.6 years, range 0.2 to 18 years). Answers to some 
items varied or had lower sensitivity. For example, for items 5, 6.2, and 6.3 a bed partner 
would be needed to provide answers, and the situations referred to in items 6.4 and 8 were 
often obscure. In evaluation of reliability, items that enlarged the kappa coefficient were 1, 2, 
5 and 6.1 for iRBD. It can be proposed that future evaluations should use weighted scores 
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for RBDSQ-J items, which may improve the accuracy of the questionnaire. The RBDSQ-J has 
high sensitivity, specificity, and reliability and would be applicable as a screening method 
for iRBD in an elderly Japanese population. Early-onset patients (≦50 years) were reported 
to have significantly more past and present psychiatric diagnoses and antidepressant usage 
than late-onset patients (>50 years) (Teman et al., 2009). It may be necessary to validate the 
RBDSQ-J in early-onset patients. 
Nomura et al. evaluated the usefulness of the RBDSQ-J among patients with PD (Nomura et 
al., 2011). A total score of 6 points on the RBDSQ-J represented the best cut-off value for 
detecting RBD. This cut-off value for RBD secondary to PD was approximately 1 point 
higher than that reported for iRBD in studies performed by Stiasny-Kolster et al. and 
Miyamoto et al. However, the cut-off value with the RBDSQ-J for PD patients would 
become equal to the above-indicated value for iRBD patients if item 10 were removed. 
Nomura et al. showed that the RBDSQ-J may be useful for detecting RBD among a PD 
population regardless of the RBD symptoms. In addition, positivity for item 6.1 might 
represent a key criterion for analyzing populations with non-violent RBD. 
5.4 RBDQ-HK  
The existing RBD questionnaires may overlook the prevalence, frequency and severity of 
the clinical symptoms. There remains an obstacle for physicians to quantitatively observe 
and monitor treatment progress in clinical settings without the availability of timely PSG. 
Screening instruments for diagnosis of RBD are limited and there are none for quantifying 
the severity of the disease. Li et al. developed and validated a 13-item self-reported RBD 
questionnaire for diagnostic and monitoring purposes (Li et al., 2010). The patient always 
answered and the bed partner sometimes also answered in addition to the patient. Items 
1-5 (Q1-Q5) were pertinent to patients’ dreams and nightmares and the last eight items 
(Q6-Q13) elicited information on the typical behavioral consequences as a result of 
patients’ dream enactments. Each item assesses two scales: lifetime occurrence and recent 
1-yr frequency (5 point scale: 3 times or above per week; 1-2 times per week; once or a few 
times per month; once or few times per year; none). Scores are weighted in 7/13 questions 
according to the clinical importance of the behavioral manifestations of RBD. Scores range 
from 0-100. In a study to validate the instrument, 107 PSG-confirmed RBD patients (mean 
age 62.5 y) with the diagnosis of cryptogenic RBD, symptomatic RBD (PD, dementia, PD 
with dementia, narcolepsy), RBD-like disorder) and 107 controls (mean age 55.3 y) 
participated. The best RBDQ-HK cut-off score for RBD detection was 18-19, with 82% 
sensitivity, 87% specificity, and 86% positive predictive value; there was high test-retest 
reliability. Among the RBD cases, the scores of RBDQ-HK based on patients’ self-reports 
were slightly lower compared to those provided by both patients and their relatives (e.g., 
bed partner)[self-report: 40.56(21.26) vs. self and relatives: 54.89(17.34), p=0.05]. The 
RBDQ-HK can be completed by patients with or without other informants such as a bed 
partner. However, abnormal nocturnal behaviors can go unnoticed in some RBD cases 
(e.g., when there is no assault or injury to self or bed partner), making the sensitivity of 
the RBDQ-HK different between those living and sleeping on their own and those living 
and sleeping with others. Hence, input on RBDQ-HK from relatives of patients is 
encouraged as it may enhance accuracy of the diagnosis and provide a better appraisal of 
treatment progress.  
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6. Conclusion 
We have described screening methods for RBD as well as some of the available RBD 
screening questionnaires. All of the questionnaires had high sensitivity in screening for 
RBD, but lower specificity. There were some problems and limitations related to these 
instruments. These validation studies were mainly performed in middle aged and elderly 
subjects. Therefore, validation of RBD screening questionnaires should be done in younger 
people. In the case of self-reported questionnaires, information from a bed partner is useful 
in achieving higher sensitivity and specificity for the instrument. Boeve suggested that the 
MSQ likely to be more appropriate for use in those with cognitive impairment/dementia 
since the responses are provided by bed partners (Boeve, 2010a). In any of the instruments 
that might be applied but are unable or unwilling to undergo PSG, or who have little or no 
apparent REM sleep during PSG, then a diagnosis of probable RBD would be justified 
(Boeve, 2010a). OSAS may represent a confounding factor in the clinical diagnosis of RBD 
(Comella et al., 2002). To differentiate RBD from OSAS, simultaneously screening for OSAS 
by pulse oxymetry may be useful. It is impractical to frequently perform PSG and the 
availability of PSG is often limited. Therefore, it is important to evaluate and follow up the 
severity of RBD through instruments such as RBDQ-HK. It is also necessary to develop a 
severity index for RBD. Tachibana recently developed an RBD severity index (RBDSI) in 
Japanese (Tachibana, 2009). 
In conclusion, RBD questionnaires may be applied within a stepwise diagnostic process 
(questionnaire, interview, polysomnography) for RBD (Table 5). 
 
1st step Screening Questionnaire
2nd step Interview Sleep specialist, Neurologist 
3rd step Final diagnosis Video PSG
Table 5. Diagnostic process for RBD 
7. APPENDIX 
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